New shot helps High-Risk patients hit tough cholesterol targets
NCT ID NCT05192941
First seen Apr 20, 2026 · Last updated May 08, 2026 · Updated 4 times
Summary
This study tested whether adding inclisiran to standard cholesterol-lowering therapy helps more high-risk patients reach their LDL (bad) cholesterol goals. About 1,770 adults with very high or high cardiovascular risk took part. Results showed that more patients on inclisiran achieved their target LDL levels compared to those on placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERCHOLESTEROLEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis Investigative Site
Sofia, Bulgaria, 1202, Bulgaria
-
Novartis Investigative Site
Burgas, Burgas, 8000, Bulgaria
-
Novartis Investigative Site
Burgas, 8001, Bulgaria
-
Novartis Investigative Site
Gabrovo, 5300, Bulgaria
-
Novartis Investigative Site
Pleven, 5800, Bulgaria
-
Novartis Investigative Site
Plovdiv, 4002, Bulgaria
-
Novartis Investigative Site
Rousse, 7000, Bulgaria
-
Novartis Investigative Site
Sofia, 1233, Bulgaria
-
Novartis Investigative Site
Sofia, 1606, Bulgaria
-
Novartis Investigative Site
Sofia, 1618, Bulgaria
-
Novartis Investigative Site
Stara Zagora, 6000, Bulgaria
-
Novartis Investigative Site
Varna, 9010, Bulgaria
-
Novartis Investigative Site
Veliko Tarnovo, 5000, Bulgaria
-
Novartis Investigative Site
Chlumec nad Cidlinou, Chlumec Nad Cidlinou, 503 51, Czechia
-
Novartis Investigative Site
Přerov, Olomouc Region, 750 02, Czechia
-
Novartis Investigative Site
Hlučín, 748 01, Czechia
-
Novartis Investigative Site
Hodonín, 695 01, Czechia
-
Novartis Investigative Site
Mělník, 276 01, Czechia
-
Novartis Investigative Site
Olomouc, 772 00, Czechia
-
Novartis Investigative Site
Olomouc, 779 00, Czechia
-
Novartis Investigative Site
Pardubice, 532 03, Czechia
-
Novartis Investigative Site
Slaný, 274 01, Czechia
-
Novartis Investigative Site
Trutnov, 460 63, Czechia
-
Novartis Investigative Site
Pärnu, 80018, Estonia
-
Novartis Investigative Site
Tallinn, 10138, Estonia
-
Novartis Investigative Site
Tallinn, 13419, Estonia
-
Novartis Investigative Site
Tartu, 50406, Estonia
-
Novartis Investigative Site
Amiens, 80054, France
-
Novartis Investigative Site
Chambéry, 73000, France
-
Novartis Investigative Site
Le Chesnay, 78150, France
-
Novartis Investigative Site
Le Kremlin-Bicêtre, 94275, France
-
Novartis Investigative Site
Lille, 59000, France
-
Novartis Investigative Site
Marseille, 13005, France
-
Novartis Investigative Site
Nantes, 44093, France
-
Novartis Investigative Site
Paris, 75013, France
-
Novartis Investigative Site
Valenciennes, 59300, France
-
Novartis Investigative Site
Mannheim, Baden-Wurttemberg, 68305, Germany
-
Novartis Investigative Site
Stuttgart, Baden-Wurttemberg, 70376, Germany
-
Novartis Investigative Site
Lichtenfels, Bavaria, 96215, Germany
-
Novartis Investigative Site
Muehldorf Am Inn, Bavaria, 84453, Germany
-
Novartis Investigative Site
Munich, Bavaria, 81377, Germany
-
Novartis Investigative Site
Nuremberg, Bavaria, 90402, Germany
-
Novartis Investigative Site
Regensburg, Bavaria, 93053, Germany
-
Novartis Investigative Site
Frankfurt am Main, Hesse, 60590, Germany
-
Novartis Investigative Site
Frankfurt am Main, Hesse, 60594, Germany
-
Novartis Investigative Site
Frankfurt am Main, Hesse, 65929, Germany
-
Novartis Investigative Site
Langen, Hesse, 63225, Germany
-
Novartis Investigative Site
Göttingen, Lower Saxony, 37075, Germany
-
Novartis Investigative Site
Hanover, Lower Saxony, 30159, Germany
-
Novartis Investigative Site
Hanover, Lower Saxony, 30449, Germany
-
Novartis Investigative Site
Winsen, Lower Saxony, 21423, Germany
-
Novartis Investigative Site
Cologne, North Rhine-Westphalia, 51065, Germany
-
Novartis Investigative Site
Essen, North Rhine-Westphalia, 45355, Germany
-
Novartis Investigative Site
Löhne, North Rhine-Westphalia, 32584, Germany
-
Novartis Investigative Site
Kaiserslautern, Rhineland-Palatinate, 67655, Germany
-
Novartis Investigative Site
Saint Ingbert, Saarland, 66386, Germany
-
Novartis Investigative Site
Bad Gottleuba, Saxony, 01816, Germany
-
Novartis Investigative Site
Dresden, Saxony, 01099, Germany
-
Novartis Investigative Site
Dresden, Saxony, 01307, Germany
-
Novartis Investigative Site
Leipzig, Saxony, 04103, Germany
-
Novartis Investigative Site
Schleswig, Schleswig-Holstein, 24837, Germany
-
Novartis Investigative Site
Bad Homburg, 61348, Germany
-
Novartis Investigative Site
Bad Krozingen, 79189, Germany
-
Novartis Investigative Site
Bad Oeynhausen, 32545, Germany
-
Novartis Investigative Site
Bamberg, 96049, Germany
-
Novartis Investigative Site
Berlin, 10367, Germany
-
Novartis Investigative Site
Berlin, 10559, Germany
-
Novartis Investigative Site
Berlin, 10787, Germany
-
Novartis Investigative Site
Berlin, 10789, Germany
-
Novartis Investigative Site
Berlin, 13347, Germany
-
Novartis Investigative Site
Berlin, 13353, Germany
-
Novartis Investigative Site
Bochum, 44789, Germany
-
Novartis Investigative Site
Bremen, 28277, Germany
-
Novartis Investigative Site
Coburg, 96450, Germany
-
Novartis Investigative Site
Cologne, 51069, Germany
-
Novartis Investigative Site
Dessau, 06846, Germany
-
Novartis Investigative Site
Dresden, 01307, Germany
-
Novartis Investigative Site
Duisburg, 47051, Germany
-
Novartis Investigative Site
Erfurt, 99089, Germany
-
Novartis Investigative Site
Erfurt, 99097, Germany
-
Novartis Investigative Site
Essen, 45277, Germany
-
Novartis Investigative Site
Essen, 45355, Germany
-
Novartis Investigative Site
Essen, 45359, Germany
-
Novartis Investigative Site
Fulda, 36037, Germany
-
Novartis Investigative Site
Gelnhausen, 63571, Germany
-
Novartis Investigative Site
Gladbeck, 45968, Germany
-
Novartis Investigative Site
Hamburg, 22041, Germany
-
Novartis Investigative Site
Hamburg, 22607, Germany
-
Novartis Investigative Site
Haßloch, 67454, Germany
-
Novartis Investigative Site
Hennigsdorf, 16761, Germany
-
Novartis Investigative Site
Hoyerswerda, 02977, Germany
-
Novartis Investigative Site
Kassel, 34121, Germany
-
Novartis Investigative Site
Kiel, 24105, Germany
-
Novartis Investigative Site
Lüneburg, 21339, Germany
-
Novartis Investigative Site
Magdeburg, 39110, Germany
-
Novartis Investigative Site
Magdeburg, 39120, Germany
-
Novartis Investigative Site
Mainz, 55131, Germany
-
Novartis Investigative Site
Mannheim, 68165, Germany
-
Novartis Investigative Site
Markkleeberg, 04416, Germany
-
Novartis Investigative Site
Münster, 48149, Germany
-
Novartis Investigative Site
Papenburg, 26871, Germany
-
Novartis Investigative Site
Pirna, 01796, Germany
-
Novartis Investigative Site
Potsdam, 14471, Germany
-
Novartis Investigative Site
Reinfeld, 23858, Germany
-
Novartis Investigative Site
Rostock, 18057, Germany
-
Novartis Investigative Site
Rüdersdorf, 15562, Germany
-
Novartis Investigative Site
Singen, 78224, Germany
-
Novartis Investigative Site
Stuttgart, 70378, Germany
-
Novartis Investigative Site
Wallerfing, 94574, Germany
-
Novartis Investigative Site
Warendorf, 48231, Germany
-
Novartis Investigative Site
Wuppertal, 42117, Germany
-
Novartis Investigative Site
Daugavpils, LV-5417, Latvia
-
Novartis Investigative Site
Ogre, 5001, Latvia
-
Novartis Investigative Site
Riga, 1012, Latvia
-
Novartis Investigative Site
Riga, LV 1002, Latvia
-
Novartis Investigative Site
Riga, LV-1001, Latvia
-
Novartis Investigative Site
Riga, LV-1012, Latvia
-
Novartis Investigative Site
Krosno, Krosno, 38-400, Poland
-
Novartis Investigative Site
Krakow, Maloposkie, 31-271, Poland
-
Novartis Investigative Site
Szczecin, West Pomeranian Voivodeship, 71-528, Poland
-
Novartis Investigative Site
Gdynia, 81-157, Poland
-
Novartis Investigative Site
Katowice, 40-648, Poland
-
Novartis Investigative Site
Krakow, 31-216, Poland
-
Novartis Investigative Site
Rzeszów, 35-055, Poland
-
Novartis Investigative Site
Skierniewice, 96-100, Poland
-
Novartis Investigative Site
Tarnów, 33-100, Poland
-
Novartis Investigative Site
Málaga, Andalusia, 29009, Spain
-
Novartis Investigative Site
Seville, Andalusia, 41014, Spain
-
Novartis Investigative Site
Sanlucar Barrameda, Cadiz, 11540, Spain
-
Novartis Investigative Site
Barcelona, Catalonia, 08003, Spain
-
Novartis Investigative Site
Majadahonda, Madrid, 28222, Spain
-
Novartis Investigative Site
San Sebastian Reyes, Madrid, 28702, Spain
-
Novartis Investigative Site
Oviedo, Principality of Asturias, 33011, Spain
-
Novartis Investigative Site
Barcelona, 08035, Spain
-
Novartis Investigative Site
Córdoba, 14004, Spain
-
Novartis Investigative Site
Seville, 41013, Spain
Conditions
Explore the condition pages connected to this study.